The latter peptidases can be blocked by ACE inhibitors (ACEI) and SARS-CoV2 or DPP-IV inhibitors (gliptins), respectively, which may all cause drug-induced angioedema by the inhibition of BK/kallidin breakdown [38–40]. Here, DPP4 is linked to angioedema.